These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9173721)
21. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database). Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951 [TBL] [Abstract][Full Text] [Related]
23. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
24. Intensive lipid-lowering therapy in patients with coronary heart disease. Lauderdale SA; Sheehan AH Ann Pharmacother; 2005 Feb; 39(2):329-34. PubMed ID: 15613464 [TBL] [Abstract][Full Text] [Related]
25. Niacin-based therapy for dyslipidemia: past evidence and future advances. Ito MK Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703 [TBL] [Abstract][Full Text] [Related]
26. Advances in drug treatment of dyslipidemia: focus on atorvastatin. Davignon J Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539 [TBL] [Abstract][Full Text] [Related]
27. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis. Kuryata OV; Yegorova YV Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629 [TBL] [Abstract][Full Text] [Related]
28. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA; Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368 [TBL] [Abstract][Full Text] [Related]
29. Management of dyslipidemia in primary care. Alzahrani T; Marrat S; Haider A Can J Cardiol; 2003 Dec; 19(13):1499-502. PubMed ID: 14760440 [TBL] [Abstract][Full Text] [Related]
30. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure. Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871 [TBL] [Abstract][Full Text] [Related]
31. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia]. Kovács I; Tarján J; Császár A Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of hyperlipidemia]. Yoshino G Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052 [TBL] [Abstract][Full Text] [Related]
33. [Regression of coronary arteriosclerosis by treatment of disorders of lipid metabolism? Initial clinical results and methodologic problems]. von Essen R Internist (Berl); 1992 Jan; 33(1):62-6. PubMed ID: 1551764 [No Abstract] [Full Text] [Related]
34. Strategy for diagnosis and treatment of hyperlipidemia. Erkelens DW Ther Umsch; 1990 Jun; 47(6):443-7. PubMed ID: 2197753 [TBL] [Abstract][Full Text] [Related]
35. [Lipid-lowering medication--indications and possible hazards. Report from a hearing]. Aursnes I; Osnes JB; Platou ES; Smiseth OA Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2930-2. PubMed ID: 8236199 [TBL] [Abstract][Full Text] [Related]
36. Lipid-lowering therapy and its effect on atherosclerosis. Thompson GR Postgrad Med J; 1989; 65 Suppl 1():S22-5. PubMed ID: 2695906 [No Abstract] [Full Text] [Related]
37. Regression of coronary artery disease: the role of plaque biology. Valle BK; Valle GA; Lemberg L Am J Crit Care; 1995 Nov; 4(6):481-4. PubMed ID: 8556091 [TBL] [Abstract][Full Text] [Related]